CD19 and COVID-19: The reduction of lymphocytes in COVID-19 also affects B cells and NK (natural killer) cells, as suggested by other studies, highlighting a significant reduction of CD19+ and NK cell count in hospitalized patients, which correlated with progression of disease and death [34,40].